Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review
- PMID: 29306522
- PMCID: PMC6752720
- DOI: 10.1016/j.clcc.2017.12.001
Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review
Abstract
Within gastrointestinal malignancies, primary hepatocellular carcinoma and pancreatic ductal adenocarcinoma (PDAC) are frequently associated with visceral thromboses (VT). Thrombus formation in the portal (PVT), mesenteric (MVT), or splenic vein (SVT) system leads to portal hypertension and intestinal ischemia. VT in PDAC may convey a risk of increased distal thrombosis and poses therapeutic uncertainty regarding the role of anticoagulation. An increasing number of reports describe VT associated with PDAC. It is possible that early diagnosis of these events may help reduce morbidity and speculatively improve oncologic outcomes. To perform a systematic review to study PVT, MVT, and SVT associated with PDAC, and to provide a comprehensive review. Medline/PubMed, Embase, Web of Science, Scopus, and the Cochrane Library. Data Extraction and Assessment: Two blinded independent observers extracted and assessed the studies for diagnosis of PVT, MVT, and SVT in PDAC. Studies were restricted to English-language literature published between 2007 and 2016. Eleven articles were identified. Five case reports and 7 retrospective studies were found, with a total of 127 patients meeting the inclusion criteria. The mean age at diagnosis was 64 years. PVT was found in 35% (n = 46), SVT in 52% (n = 65), and MVT in 13% (n = 15). Mean follow-up time was 26 months. Only 3 of the selected articles studied the impact of anticoagulation in VT. All patients with nonvisceral thrombosis (eg, deep-vein thrombosis, pulmonary emboli) were therapeutically treated; in contrast, patients with VT only rarely received treatment. VT in PDAC is a frequent finding at diagnosis or during disease progression. Evidence to guide treatment choices is limited, and current management is based on inferred experience from nononcologic settings. Anticoagulation appears to be safe in VT, with most of the large studies recommending a careful assessment for patients at a high risk of bleeding.
Keywords: Deep venous thrombosis; Mesenteric vein thrombosis; Portal vein thrombosis; Splanchnic vein thrombosis; Splenic vein thrombosis.
Copyright © 2017 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures




Similar articles
-
Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.Clin Colorectal Cancer. 2018 Jun;17(2):121-128. doi: 10.1016/j.clcc.2018.01.008. Epub 2018 Jan 31. Clin Colorectal Cancer. 2018. PMID: 29477452 Free PMC article.
-
Mesenteric vein thrombosis can be safely treated with anticoagulation but is associated with significant sequelae of portal hypertension.J Vasc Surg Venous Lymphat Disord. 2016 Oct;4(4):400-6. doi: 10.1016/j.jvsv.2016.05.003. Epub 2016 Jun 16. J Vasc Surg Venous Lymphat Disord. 2016. PMID: 27638992
-
Splanchnic vein thrombosis in patients with pancreatitis: Outcome and impact of anticoagulation.Pancreatology. 2025 May;25(3):325-332. doi: 10.1016/j.pan.2025.03.009. Epub 2025 Mar 24. Pancreatology. 2025. PMID: 40204536
-
Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review.Dig Liver Dis. 2021 Aug;53(8):937-949. doi: 10.1016/j.dld.2021.05.021. Epub 2021 May 26. Dig Liver Dis. 2021. PMID: 34120860 Free PMC article.
-
Portal Vein Thrombosis After Splenic and Pancreatic Surgery.Adv Exp Med Biol. 2017;906:241-251. doi: 10.1007/5584_2016_119. Adv Exp Med Biol. 2017. PMID: 27638624 Review.
Cited by
-
Incidence and Management of Splanchnic Vein Thrombosis in Pancreatic Diseases.United European Gastroenterol J. 2025 Feb;13(1):86-96. doi: 10.1002/ueg2.12744. Epub 2025 Jan 1. United European Gastroenterol J. 2025. PMID: 39743752 Free PMC article. Review.
-
ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.Oncologist. 2020 Feb;25(2):e284-e290. doi: 10.1634/theoncologist.2019-0510. Epub 2019 Oct 22. Oncologist. 2020. PMID: 32043787 Free PMC article.
-
Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study.Ther Adv Med Oncol. 2024 Jun 5;16:17588359241258440. doi: 10.1177/17588359241258440. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38845791 Free PMC article.
-
Splenic Vein Thrombosis, Non-Cirrhotic Portal Hypertension, and Gastric Varices in a Patient With Ovarian Carcinoma.J Med Cases. 2025 Jun 16;16(6):222-225. doi: 10.14740/jmc5127. eCollection 2025 Jun. J Med Cases. 2025. PMID: 40642742 Free PMC article.
-
Trends and In-Hospital Outcomes of Splanchnic Vein Thrombosis Associated with Gastrointestinal Malignancies: A Nationwide Analysis.Gastrointest Tumors. 2021 Apr;8(2):71-80. doi: 10.1159/000513368. Epub 2021 Feb 9. Gastrointest Tumors. 2021. PMID: 33981685 Free PMC article.
References
-
- Lisowski FP, Oxnard CE. Anatomical Terms And Their Derivation. River Edge, SG: World Scientific; 2007.
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015. January 5;65(1):5–29. - PubMed
-
- Dumitrascu DL, Suciu O, Grad C, Gheban D. Thrombotic Complications of Pancreatic Cancer: Classical Knowledge Revisited. Dig Dis. 2010;28(2):350–4. - PubMed
-
- Shah MM, Saif MW. Pancreatic cancer and thrombosis. Highlights from the “2010 ASCO Annual Meeting.” Chicago, IL, USA June 4-8, 2010 JOP; 2010;11(4):331–3. - PubMed
-
- Epstein AS, O'Reilly EM. Exocrine pancreas cancer and thromboembolic events: a systematic literature review. J Natl Compr Canc Netw. 2012. July 1;10(7):835–46. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical